# S100A16 drives hepatocellular carcinoma by promoting KCNJ8-mediated choline metabolic dysregulation and immunosuppression

Source: [Biological sciences : nature.com subject feeds](https://www.nature.com/articles/s41419-026-09397-3) · 2026-11-18 · Life
Page: https://themorning.science/story/s100a16-drives-hepatocellular-carcinoma-by-promoting-kcnj8-mediated-choline-meta-ab6d40dd6ad69945
Kind: research · Impact: low

## In brief

- A Nature subject-feed item reports that S100A16 promotes hepatocellular carcinoma.
- The reported mechanism involves KCNJ8-mediated choline metabolic dysregulation and immunosuppression.
- The source provided no summary, so further experimental details are not available from the sources given.

## Why it matters

It is a basic research finding on a possible mechanism in liver cancer, relevant to researchers studying tumour metabolism and immune evasion, but it has no established clinical consequence from the information provided.

## Timeline

- 2026-11-18: Article listed in Nature subject feed (Biological sciences)

## Coverage

- [S100A16 drives hepatocellular carcinoma by promoting KCNJ8-mediated choline metabolic dysregulation and immunosuppression](https://www.nature.com/articles/s41419-026-09397-3) — Biological sciences : nature.com subject feeds, 2026-11-18

Tags: hepatocellular carcinoma, s100a16, kcnj8, choline metabolism, immunosuppression, cancer biology

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
